SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-010189
Filing Date
2023-05-18
Accepted
2023-05-18 16:05:25
Documents
12
Period of Report
2023-05-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K nbse-20230512x8k.htm   iXBRL 8-K 39594
  Complete submission text file 0001558370-23-010189.txt   156407

Data Files

Seq Description Document Type Size
2 EX-101.SCH nbse-20230512.xsd EX-101.SCH 3155
3 EX-101.LAB nbse-20230512_lab.xml EX-101.LAB 15267
4 EX-101.PRE nbse-20230512_pre.xml EX-101.PRE 9942
6 EXTRACTED XBRL INSTANCE DOCUMENT nbse-20230512x8k_htm.xml XML 4692
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 23936052
SIC: 2834 Pharmaceutical Preparations